Adaptimmune competitorsClear all

Adaptimmune's top competitors include Bellicum Pharmaceuticals, Meissa Vaccines, CosmosID and TCR2 Therapeutics.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Meissa Vaccines
Meissa Vaccines
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
CosmosID
CosmosID
CosmosID develops softwarefor identifyingpathogens present in clinical, environmental, and other research samples.
TCR2 Therapeutics
TCR2 Therapeutics
TCR , Inc. is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy.
Founding Date
Founding Date
2008
Founding Date
2004
Founding Date
2014
Founding Date
2008
Founding Date
2015
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Locations
Houston, US HQ
Houston, US
South San Francisco, US
Locations
South San Francisco, US HQ
Redwood City, US
Locations
Rockville, US HQ
Watford, GB
Locations
Cambridge, US HQ
Employees
Employees
4007% decrease
Employees
10738% decrease
Employees
225% increase
Employees
274% increase
Employees
445% increase
Valuation ($)
Valuation ($)
749.4 m
Valuation ($)
26.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
742.9 m
Twitter followers
Twitter followers
3.4 k
Twitter followers
557
Twitter followers
127
Twitter followers
600
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
8.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
288563
Alexa Website Rank
330946
Alexa Website Rank
192379
Alexa Website Rank
224475
Alexa Website Rank
462124
Employee Rating
Employee Rating
3.5
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.6

Financial

Revenue (est.)
Revenue (est.)
$4m (FY, 2020)
Revenue (est.)
$500k (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($130.1m) (FY, 2020)
Net income
($7.7m) (FY, 2020)
Net income
N/A
Net income
N/A
Net income
($67.1m) (FY, 2020)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 30m (over 1 year ago)
Latest funding round
$ 6m (over 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 107.5m
Total funding raised
N/A
Total funding raised
$ 33.4m
Total funding raised
$ 7.2m
Total funding raised
$ 173.3m
For sources of this data, please see the company profile

View company profiles

Bellicum Pharmaceuticals
HQ
Houston, US
Employees
107↓ 38% decrease

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company
Meissa Vaccines
HQ
South San Francisco, US
Employees
22↑ 5% increase

Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.

View company
CosmosID
HQ
Rockville, US
Employees
27↑ 4% increase

CosmosID develops softwarefor identifyingpathogens present in clinical, environmental, and other research samples.

View company
TCR2 Therapeutics
HQ
Cambridge, US
Employees
44↑ 5% increase

TCR , Inc. is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy.

View company